RT Book, Section
A1 Lopes, Luís R.
A1 Elliott, Perry M.
A2 Fuster, Valentin
A2 Harrington, Robert A.
A2 Narula, Jagat
A2 Eapen, Zubin J.
SR Print(0)
ID 1161732830
T1 HYPERTROPHIC CARDIOMYOPATHIES
T2 Hurst's The Heart, 14e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071843249
LK accesscardiology.mhmedical.com/content.aspx?aid=1161732830
RD 2024/04/23
AB Hypertrophic  cardiomyopathy  (HCM)  is  defined  as  left  ventricular  (LV)  hypertrophy  in  the  absence  of  abnormal  loading  conditions,  such  as  severe  hypertension  or  valve  disease,  sufficient  to  provoke  the  observed  phenotype.1  It  occurs  in  approximately  1  in  every  500  adults,2,3,4,5,6,7  with  a  slightly  higher  prevalence  in  males,  but  with  no  significant  differences  across  ethnicities  or  geographical  locations.  Ventricular  hypertrophy  frequently  develops  during  periods  of  rapid  somatic  growth,  but  can  appear  de  novo  at  any  time  from  infancy  to  old  age.